| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 2.11e-07 | 46 | 23 | 4 | GO:0030020 | |
| GeneOntologyMolecularFunction | fatty-acyl-CoA synthase activity | 3.54e-05 | 8 | 23 | 2 | GO:0004321 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.86e-05 | 188 | 23 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | medium-chain fatty acid-CoA ligase activity | 6.94e-05 | 11 | 23 | 2 | GO:0031956 | |
| GeneOntologyMolecularFunction | C-acyltransferase activity | 2.63e-04 | 21 | 23 | 2 | GO:0016408 | |
| GeneOntologyMolecularFunction | fatty acid ligase activity | 4.06e-04 | 26 | 23 | 2 | GO:0015645 | |
| GeneOntologyMolecularFunction | structural molecule activity | 4.08e-04 | 891 | 23 | 6 | GO:0005198 | |
| GeneOntologyMolecularFunction | CoA-ligase activity | 4.38e-04 | 27 | 23 | 2 | GO:0016405 | |
| GeneOntologyMolecularFunction | acid-thiol ligase activity | 5.78e-04 | 31 | 23 | 2 | GO:0016878 | |
| GeneOntologyMolecularFunction | nuclear androgen receptor binding | 6.56e-04 | 33 | 23 | 2 | GO:0050681 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 1.01e-03 | 41 | 23 | 2 | GO:0016877 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 1.63e-03 | 1160 | 23 | 6 | GO:0030674 | |
| GeneOntologyMolecularFunction | acyltransferase activity, transferring groups other than amino-acyl groups | 2.48e-03 | 238 | 23 | 3 | GO:0016747 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 3.59e-03 | 1356 | 23 | 6 | GO:0060090 | |
| GeneOntologyMolecularFunction | phosphoprotein binding | 7.95e-03 | 117 | 23 | 2 | GO:0051219 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | 5.10e-05 | 377 | 23 | 5 | GO:0030198 | |
| GeneOntologyBiologicalProcess | extracellular structure organization | 5.16e-05 | 378 | 23 | 5 | GO:0043062 | |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | 5.23e-05 | 379 | 23 | 5 | GO:0045229 | |
| GeneOntologyBiologicalProcess | positive regulation of protein acetylation | 1.80e-04 | 18 | 23 | 2 | GO:1901985 | |
| GeneOntologyBiologicalProcess | purine ribonucleotide metabolic process | 2.15e-04 | 512 | 23 | 5 | GO:0009150 | |
| GeneOntologyBiologicalProcess | ribonucleotide metabolic process | 2.59e-04 | 533 | 23 | 5 | GO:0009259 | |
| GeneOntologyBiologicalProcess | ribose phosphate metabolic process | 2.75e-04 | 540 | 23 | 5 | GO:0019693 | |
| GeneOntologyBiologicalProcess | positive regulation of T-helper 17 type immune response | 2.97e-04 | 23 | 23 | 2 | GO:2000318 | |
| GeneOntologyCellularComponent | costamere | 1.77e-06 | 22 | 23 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | collagen trimer | 2.44e-06 | 88 | 23 | 4 | GO:0005581 | |
| GeneOntologyCellularComponent | basement membrane | 8.97e-06 | 122 | 23 | 4 | GO:0005604 | |
| GeneOntologyCellularComponent | basement membrane collagen trimer | 3.23e-05 | 8 | 23 | 2 | GO:0098651 | |
| GeneOntologyCellularComponent | network-forming collagen trimer | 3.23e-05 | 8 | 23 | 2 | GO:0098642 | |
| GeneOntologyCellularComponent | collagen network | 3.23e-05 | 8 | 23 | 2 | GO:0098645 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 2.37e-04 | 530 | 23 | 5 | GO:0062023 | |
| GeneOntologyCellularComponent | complex of collagen trimers | 2.40e-04 | 21 | 23 | 2 | GO:0098644 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 4.36e-04 | 332 | 23 | 4 | GO:0005788 | |
| GeneOntologyCellularComponent | extracellular matrix | 6.30e-04 | 656 | 23 | 5 | GO:0031012 | |
| GeneOntologyCellularComponent | external encapsulating structure | 6.39e-04 | 658 | 23 | 5 | GO:0030312 | |
| GeneOntologyCellularComponent | sarcolemma | 1.14e-03 | 190 | 23 | 3 | GO:0042383 | |
| GeneOntologyCellularComponent | supramolecular polymer | 1.45e-03 | 1187 | 23 | 6 | GO:0099081 | |
| GeneOntologyCellularComponent | myofibril | 3.22e-03 | 273 | 23 | 3 | GO:0030016 | |
| GeneOntologyCellularComponent | T-tubule | 3.39e-03 | 79 | 23 | 2 | GO:0030315 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 3.81e-03 | 290 | 23 | 3 | GO:0043292 | |
| Domain | Collagen | 3.31e-06 | 85 | 23 | 4 | PF01391 | |
| Domain | Collagen | 3.31e-06 | 85 | 23 | 4 | IPR008160 | |
| Domain | AMP-bd_C | 1.95e-04 | 17 | 23 | 2 | IPR025110 | |
| Domain | AMP-binding_C | 1.95e-04 | 17 | 23 | 2 | PF13193 | |
| Domain | AMP-binding_CS | 4.63e-04 | 26 | 23 | 2 | IPR020845 | |
| Domain | AMP_BINDING | 5.38e-04 | 28 | 23 | 2 | PS00455 | |
| Domain | AMP-binding | 6.18e-04 | 30 | 23 | 2 | PF00501 | |
| Domain | AMP-dep_Synth/Lig | 6.18e-04 | 30 | 23 | 2 | IPR000873 | |
| Domain | Cadherin-like | 8.89e-03 | 116 | 23 | 2 | IPR015919 | |
| Domain | PDZ | 1.29e-02 | 141 | 23 | 2 | PF00595 | |
| Domain | PDZ | 1.41e-02 | 148 | 23 | 2 | SM00228 | |
| Domain | - | 1.45e-02 | 150 | 23 | 2 | 2.30.42.10 | |
| Domain | PDZ | 1.47e-02 | 151 | 23 | 2 | PS50106 | |
| Domain | PDZ | 1.49e-02 | 152 | 23 | 2 | IPR001478 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.14e-05 | 41 | 19 | 3 | MM15538 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 2.65e-05 | 44 | 19 | 3 | M27812 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 3.04e-05 | 46 | 19 | 3 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 3.91e-05 | 50 | 19 | 3 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 7.11e-05 | 61 | 19 | 3 | M27103 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 7.11e-05 | 61 | 19 | 3 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 8.21e-05 | 64 | 19 | 3 | M26953 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 9.42e-05 | 67 | 19 | 3 | M26999 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 1.27e-04 | 74 | 19 | 3 | M160 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.37e-04 | 76 | 19 | 3 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 2.26e-04 | 90 | 19 | 3 | M631 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 6.05e-04 | 300 | 19 | 4 | M610 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.27e-04 | 140 | 19 | 3 | M587 | |
| Pathway | KEGG_BUTANOATE_METABOLISM | 9.41e-04 | 34 | 19 | 2 | M3397 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 9.41e-04 | 34 | 19 | 2 | MM15531 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.11e-03 | 37 | 19 | 2 | M27797 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.30e-03 | 40 | 19 | 2 | MM15000 | |
| Pathway | REACTOME_SUMOYLATION_OF_TRANSCRIPTION_COFACTORS | 1.57e-03 | 44 | 19 | 2 | M27295 | |
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 15007166 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 20833135 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 24796807 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 15361761 | ||
| Pubmed | 4.18e-07 | 2 | 23 | 2 | 11470804 | ||
| Pubmed | 1.25e-06 | 3 | 23 | 2 | 21940993 | ||
| Pubmed | 2.51e-06 | 4 | 23 | 2 | 17185750 | ||
| Pubmed | 2.99e-06 | 153 | 23 | 4 | 25037231 | ||
| Pubmed | SMARCA3, a chromatin-remodeling factor, is required for p11-dependent antidepressant action. | 8.77e-06 | 7 | 23 | 2 | 23415230 | |
| Pubmed | Retinal ganglion cell axon sorting at the optic chiasm requires dystroglycan. | 1.50e-05 | 9 | 23 | 2 | 30149005 | |
| Pubmed | 2.56e-05 | 549 | 23 | 5 | 38280479 | ||
| Pubmed | Basement membrane fragility underlies embryonic lethality in fukutin-null mice. | 2.75e-05 | 12 | 23 | 2 | 15837576 | |
| Pubmed | Proteomic analysis reveals new cardiac-specific dystrophin-associated proteins. | 3.79e-05 | 14 | 23 | 2 | 22937058 | |
| Pubmed | DNA polymerase POLD1 promotes proliferation and metastasis of bladder cancer by stabilizing MYC. | 6.42e-05 | 118 | 23 | 3 | 37105989 | |
| Pubmed | 8.72e-05 | 21 | 23 | 2 | 23325811 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 9.57e-05 | 135 | 23 | 3 | 28675934 | |
| Pubmed | 1.21e-04 | 146 | 23 | 3 | 27068509 | ||
| Pubmed | 1.32e-04 | 777 | 23 | 5 | 35844135 | ||
| Pubmed | 1.47e-04 | 156 | 23 | 3 | 32850835 | ||
| Pubmed | 1.80e-04 | 30 | 23 | 2 | 35830813 | ||
| Pubmed | 2.06e-04 | 175 | 23 | 3 | 28071719 | ||
| Pubmed | Nuclear High Mobility Group A2 (HMGA2) Interactome Revealed by Biotin Proximity Labeling. | 2.75e-04 | 37 | 23 | 2 | 36835656 | |
| Pubmed | 3.05e-04 | 39 | 23 | 2 | 33580754 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | 3.11e-04 | 934 | 23 | 5 | 33916271 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | 3.37e-04 | 1496 | 23 | 6 | 32877691 | |
| Pubmed | 4.08e-04 | 542 | 23 | 4 | 14651853 | ||
| Pubmed | 4.13e-04 | 222 | 23 | 3 | 37071664 | ||
| Pubmed | 4.23e-04 | 547 | 23 | 4 | 37267103 | ||
| Pubmed | 5.51e-04 | 245 | 23 | 3 | 35652658 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 5.71e-04 | 248 | 23 | 3 | 24006456 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | 6.09e-04 | 1082 | 23 | 5 | 38697112 | |
| Interaction | EHMT2 interactions | 2.41e-05 | 315 | 23 | 5 | int:EHMT2 | |
| Interaction | GJB7 interactions | 3.46e-05 | 56 | 23 | 3 | int:GJB7 | |
| Interaction | GLRX3 interactions | 6.01e-05 | 191 | 23 | 4 | int:GLRX3 | |
| Interaction | C1QL4 interactions | 7.67e-05 | 73 | 23 | 3 | int:C1QL4 | |
| Interaction | MBD1 interactions | 8.99e-05 | 77 | 23 | 3 | int:MBD1 | |
| Interaction | ANXA2 interactions | 9.37e-05 | 419 | 23 | 5 | int:ANXA2 | |
| Interaction | WWTR1 interactions | 9.69e-05 | 422 | 23 | 5 | int:WWTR1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16p12 | 3.35e-03 | 172 | 23 | 2 | chr16p12 | |
| GeneFamily | Collagens | 1.02e-05 | 46 | 17 | 3 | 490 | |
| GeneFamily | Acyl-CoA synthetase family | 2.67e-04 | 26 | 17 | 2 | 40 | |
| GeneFamily | PDZ domain containing | 8.79e-03 | 152 | 17 | 2 | 1220 | |
| Coexpression | NABA_COLLAGENS | 7.12e-06 | 43 | 23 | 3 | MM17060 | |
| Coexpression | NABA_COLLAGENS | 7.63e-06 | 44 | 23 | 3 | M3005 | |
| Coexpression | GSE5589_LPS_VS_LPS_AND_IL6_STIM_IL6_KO_MACROPHAGE_45MIN_UP | 2.60e-05 | 200 | 23 | 4 | M6620 | |
| Coexpression | NABA_CORE_MATRISOME | 8.36e-05 | 270 | 23 | 4 | MM17057 | |
| Coexpression | NABA_CORE_MATRISOME | 8.97e-05 | 275 | 23 | 4 | M5884 | |
| ToppCell | LV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 4.03e-08 | 190 | 23 | 5 | 12992ec80a7b4f4f17de693f0719ee061a9918fd | |
| ToppCell | LV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.14e-08 | 191 | 23 | 5 | d36565257ccba8c1bbed2c1c01be66a9cbb5f834 | |
| ToppCell | LA-02._Fibroblast_II|LA / Chamber and Cluster_Paper | 4.47e-08 | 194 | 23 | 5 | 234d1494c114cce77c619708bbcd8d5ce805f19b | |
| ToppCell | LA-02._Fibroblast_II|World / Chamber and Cluster_Paper | 4.59e-08 | 195 | 23 | 5 | a78b605b49acd8c9d68716266ca269dafcd910b9 | |
| ToppCell | LA-01._Fibroblast_I|LA / Chamber and Cluster_Paper | 2.02e-06 | 179 | 23 | 4 | dcb6ec9ae72b13fe388b72dace2815293fafe8ee | |
| ToppCell | LA-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.41e-06 | 187 | 23 | 4 | 4ea486991f66c29728d127171a07b81404ec0b78 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.62e-06 | 191 | 23 | 4 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | RV-01._Fibroblast_I|RV / Chamber and Cluster_Paper | 2.67e-06 | 192 | 23 | 4 | 356160b113c3305a61ceeaff33ce3c9da0be2878 | |
| ToppCell | LV-01._Fibroblast_I|LV / Chamber and Cluster_Paper | 2.73e-06 | 193 | 23 | 4 | dc17f3b9758936d428cf17f77a1ce6d4c479b165 | |
| ToppCell | LV-02._Fibroblast_II|LV / Chamber and Cluster_Paper | 2.78e-06 | 194 | 23 | 4 | 014d2feb5db2a6a35ef759761a41e466e108c3c1 | |
| ToppCell | RV-02._Fibroblast_II|RV / Chamber and Cluster_Paper | 2.78e-06 | 194 | 23 | 4 | 11c79a8c56ece42713b04b321982e41e239f07a5 | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 2.84e-06 | 195 | 23 | 4 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Aqp5_Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.50e-05 | 111 | 23 | 3 | 84b7d4fe5839f649bc4246738d620c9cee3c4cf7 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 6.00e-05 | 149 | 23 | 3 | 5293c50b3fb41b1edaf9a97354899bd13770078c | |
| ToppCell | RA-01._Fibroblast_I|RA / Chamber and Cluster_Paper | 8.72e-05 | 169 | 23 | 3 | 6373562ab3b1765060212a6a53d6543e7e942e80 | |
| ToppCell | AT1-AT2_cells-Donor_06|World / lung cells shred on cell class, cell subclass, sample id | 9.67e-05 | 175 | 23 | 3 | bdd85ba280648a0283c1984662a34c7b840f64dd | |
| ToppCell | P03-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 9.84e-05 | 176 | 23 | 3 | f3a54038cde58326f1caed96ecca33c141bcc8b3 | |
| ToppCell | AT1_cells-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.00e-04 | 177 | 23 | 3 | 3128b8d04687acee1ac4190b2569d6328b98eaf3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 178 | 23 | 3 | a3af5d9c55858e36be0498081029ecb0acaeb3d3 | |
| ToppCell | PND28-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.02e-04 | 178 | 23 | 3 | b3b88989bd602cfb55bb5c47731deb99288a8952 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 179 | 23 | 3 | fad1fbee002fcd424c03460d695559060ce41a3f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 179 | 23 | 3 | 6d4e4b64e633b2ae8514ffa1e45829d6508dac54 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-B_cell-B_cell-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.03e-04 | 179 | 23 | 3 | 61a7cc01fae4115325fce0efaa5bacf8f9af5ba2 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.05e-04 | 180 | 23 | 3 | 39ae8586efd91536e9ac6408d26de7e6d6237c41 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-04 | 181 | 23 | 3 | e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 182 | 23 | 3 | 573771130247e869e4e58f22d4a1cb31989635cf | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.09e-04 | 182 | 23 | 3 | 6cfaa2b3b3974c13b01c943f4adb70768dcc35e4 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.09e-04 | 182 | 23 | 3 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | 3'_v3-lymph-node_spleen-Hematopoietic_Erythro-Mega-Erythrocytic_early|lymph-node_spleen / Manually curated celltypes from each tissue | 1.10e-04 | 183 | 23 | 3 | 0d56e16d4868c752c7557acec212029eb469ed05 | |
| ToppCell | COVID-19-Heart-Fib_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.14e-04 | 185 | 23 | 3 | 8f95d8e591bf7379d13f5a0545b0cb49e2b1ab5d | |
| ToppCell | P15-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.16e-04 | 186 | 23 | 3 | 521e6e007bbae73e7328153aa170cf04ca3c1093 | |
| ToppCell | wk_08-11-Mesenchymal-Myofibro_&_SMC-Vascular_SMC_2|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 1.18e-04 | 187 | 23 | 3 | 406ff9327d3109fe1e251629c4c617b00a573dc2 | |
| ToppCell | Control-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 1.18e-04 | 187 | 23 | 3 | 3a032432f780525f4f4c2a358897d9989b1ecae7 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.20e-04 | 188 | 23 | 3 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | droplet-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l17|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.20e-04 | 188 | 23 | 3 | 6c6486cae9a8f2f8200598cb4bfd3fd513eb28a3 | |
| ToppCell | COPD-Epithelial-ATI|Epithelial / Disease state, Lineage and Cell class | 1.21e-04 | 189 | 23 | 3 | 14e8e57e4db336fbef005270647983b4edf407c0 | |
| ToppCell | facs-GAT-Fat-3m|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 190 | 23 | 3 | 1d92be1b41cff59e834a9d28868f554bd1f3e471 | |
| ToppCell | E17.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.23e-04 | 190 | 23 | 3 | 15f314517ed47b12d287a12a7d18cb383310e25a | |
| ToppCell | MatrixFB-Fibroblast-C|MatrixFB / shred on cell class and cell subclass (v4) | 1.23e-04 | 190 | 23 | 3 | d0106f7a21292f0b96ce4337ec3efbb1bd78dd0a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 190 | 23 | 3 | 562ee3b025c29edf07b8b344323edb49d82f1c7e | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.23e-04 | 190 | 23 | 3 | f5fb989afabb49d64d91324570cd8c80a4b9e67d | |
| ToppCell | LAM-Epithelial-AT1|Epithelial / Condition, Lineage and Cell class | 1.25e-04 | 191 | 23 | 3 | 3457e15d1e9b36a78363d46b320c4ec46b40290a | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 191 | 23 | 3 | ce76b156b153a2c7c9f2fb8e563b69c81073fbe5 | |
| ToppCell | PND07-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.25e-04 | 191 | 23 | 3 | c006f5a6e3a32b79ac99a78304bdd5116fc0d5e0 | |
| ToppCell | P07-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.25e-04 | 191 | 23 | 3 | 0f360766490bef3495c42f6421b22a988cfc68fb | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.27e-04 | 192 | 23 | 3 | be5e246b2350398b985767b2fbede17a8dd8cc44 | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 192 | 23 | 3 | 790282d4232311df3dac4ad97c80fc53443beccc | |
| ToppCell | PND10-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.27e-04 | 192 | 23 | 3 | b2d9bffccd6264b4f12d88a0780646ee0b41969f | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 1.27e-04 | 192 | 23 | 3 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-04 | 193 | 23 | 3 | 54506c0da2f219f472b95e8935a78b657a8dec41 | |
| ToppCell | Control-B_memory-0|Control / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.29e-04 | 193 | 23 | 3 | b8d64cc0abc4a3311e172e7e48a7de0f2188effb | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.29e-04 | 193 | 23 | 3 | 2d42721fac1bee294ede47d609bebb3e7d36bf0c | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 194 | 23 | 3 | ad3eb98f94a007c5988ede06238255f5b03bee6e | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia_independent-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.31e-04 | 194 | 23 | 3 | f44394c8a6f86483063f2f5722f003a8a0a70254 | |
| ToppCell | Mesenchymal_cells-Endosteal_fibro.|Mesenchymal_cells / Lineage and Cell class | 1.31e-04 | 194 | 23 | 3 | 9a4b5de4d1d8a0aa76fed7b36548ea628f3009cc | |
| ToppCell | Mesenchymal_cells-Arteriolar_fibro.|World / Lineage and Cell class | 1.31e-04 | 194 | 23 | 3 | c1e8923a50b4138a1e4c054c0c17b7f7122aa8a9 | |
| ToppCell | E18.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.31e-04 | 194 | 23 | 3 | a281ebab117589fc922ead0a712cfe0a844c94ac | |
| ToppCell | Mesenchymal_cells-Endosteal_fibro.|World / Lineage and Cell class | 1.33e-04 | 195 | 23 | 3 | d53974d1866e23c894ffd492ea11d20422919b11 | |
| ToppCell | RV-02._Fibroblast_II|World / Chamber and Cluster_Paper | 1.33e-04 | 195 | 23 | 3 | ce90b30dcdb56d4cd925cdb79fd9d7cefd998f48 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.33e-04 | 195 | 23 | 3 | 47762d9e442fb1f6f0033e3e10f4c6e498d2c081 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-04 | 196 | 23 | 3 | 6856317cd0cdcb88fe54b4ae905d91e13495b1c4 | |
| ToppCell | cellseq-Epithelial-Epithelial_Alveolar-AT1-AT1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.35e-04 | 196 | 23 | 3 | 6731fef8c148b6681d6ed38afdf23c8213e0bbbe | |
| ToppCell | Epithelial-A_(AT1)|World / shred on cell class and cell subclass (v4) | 1.35e-04 | 196 | 23 | 3 | 484bbc6b1f58bc260964babb949d14f5df101393 | |
| ToppCell | Epithelial-Epithelial-A_(AT1)|Epithelial / shred on cell class and cell subclass (v4) | 1.35e-04 | 196 | 23 | 3 | 41b21a18125cc95bc8adde3369e4abd029cf137d | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.35e-04 | 196 | 23 | 3 | 9f39cb3de886283da34ee7511a92d94930a6c851 | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-04 | 196 | 23 | 3 | 9790340c25f446ec655f5a0b64ec3bb44ed2e1bd | |
| ToppCell | PND03-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.35e-04 | 196 | 23 | 3 | b9ceceeacbcf81976ce92adf044f0d0aa132632b | |
| ToppCell | Epithelial_cells-AT1_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.35e-04 | 196 | 23 | 3 | 6c99d29162848161c1f166a032320f87a5d5a631 | |
| ToppCell | (5)_Epi_stratified|World / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.37e-04 | 197 | 23 | 3 | 2b35bcff0637cd5af9bec1ac6bca2b59a92e2f64 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 197 | 23 | 3 | bbb7c106d5b96b8e95aeb3e5c293e104fceea234 | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.37e-04 | 197 | 23 | 3 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | normal_Lung-Epithelial_cells-AT1|Epithelial_cells / Location, Cell class and cell subclass | 1.37e-04 | 197 | 23 | 3 | 7d19b93d6853828e2a036e37c4887edb1de4503c | |
| ToppCell | ASK440-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.37e-04 | 197 | 23 | 3 | 782449c522c9e16e72bf999a73090688a3aefe06 | |
| ToppCell | PND01-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-04 | 197 | 23 | 3 | b0fb5774525ba05f60c635d42f14bb8d79bff17c | |
| ToppCell | (1)_Osterolineage_cells-(11)_OLC-2|(1)_Osterolineage_cells / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.39e-04 | 198 | 23 | 3 | 9f9dcf23ffb333105263132d87b90095642294cf | |
| ToppCell | (5)_Epithelial_cells-(5)_Epi_stratified|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 1.39e-04 | 198 | 23 | 3 | b3aec042912ce53bd86e86b6761a0604d9998ab5 | |
| ToppCell | Epithelial_cells-AT1-AT2_cells|Epithelial_cells / lung cells shred on cell class, cell subclass, sample id | 1.39e-04 | 198 | 23 | 3 | fbc46b20bcd44f2083170aacbc6f5dd00fba685c | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.39e-04 | 198 | 23 | 3 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | ASK452-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.41e-04 | 199 | 23 | 3 | 48cafe44951908d03f3c6f3e185e9cbb86fb5b3b | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-04 | 200 | 23 | 3 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-04 | 200 | 23 | 3 | db6281b5d4032116310db379d9175d790994c99c | |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.44e-04 | 200 | 23 | 3 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Clrn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.20e-03 | 100 | 23 | 2 | 2e1c6fa2b48a6e3367b76b79dec58aea9c4662e0 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Olfr558_(Mural.Rgs5Acta2.Olfr558)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.22e-03 | 101 | 23 | 2 | a05293ccd1de48ed8c7d1417f410d2c4be388c5b | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_3-MURAL_Mural.Rgs5Acta2.Olfr558_(Mural.Rgs5Acta2.Olfr558)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.22e-03 | 101 | 23 | 2 | b75b000b7899399d1e6aa692d2a4c33b41a1fe18 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-Like-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.40e-03 | 108 | 23 | 2 | d620f07243c2628494e689bbfabc14c453f4b1f4 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.50e-03 | 112 | 23 | 2 | ef8fdb35a4d295f7e4a0a4029e5965c1f17e413a | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.50e-03 | 112 | 23 | 2 | d652e6fae433a6b56bf2a448fba2cf6c5e558905 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.50e-03 | 112 | 23 | 2 | 88fcd0dc12b5c00804381fb7dd59a6a2a9f37419 | |
| ToppCell | Striatum-Endothelial-MURAL-M1(Rgs5Acta2)-M1_2-MURAL_Mural.Rgs5Acta2.Kcnj8_(Mural.Rgs5Acta2.Kcnj8)-|Striatum / BrainAtlas - Mouse McCarroll V32 | 1.50e-03 | 112 | 23 | 2 | fd4cc5190626cb262aae0a7f04559b0e9757270e | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.53e-03 | 113 | 23 | 2 | 34ae3dec5ec7585d155ea61de6adc42aa4f45226 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8-Inhibitory_Neuron.Gad1Gad2-Chat_(Nucleus_basalis_(NB))|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.53e-03 | 113 | 23 | 2 | 79ba2eb8f85e5da4c19c838df881c18ffdc450fb | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Lhx8|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.53e-03 | 113 | 23 | 2 | 91d55fe6fb1c1472867d74461f5b9e4f17db01cd | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.56e-03 | 114 | 23 | 2 | 9f0c8dfd740d50448a6c91a00e7bae4dfc9b3302 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Vip_Itih5|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.61e-03 | 116 | 23 | 2 | 605bd4fdf547cc41783e99cd78425760ef6461ef | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Serpinf1-Serpinf1_Clrn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.66e-03 | 118 | 23 | 2 | 702548d8187d54e8814375e5ae7609631fc71d5f | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sncg-Sncg_Slc17a8|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.69e-03 | 119 | 23 | 2 | 6435891e6e33e7ae07e0c3a64a66edfbeedb54be | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Serpinf1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.69e-03 | 119 | 23 | 2 | 9ffdb432ec06d12eccbc9af9d30c0d24a0a21030 | |
| ToppCell | droplet-Heart-HEART-1m-Hematologic-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-03 | 127 | 23 | 2 | 983489a69d3b1f1fe21110a862ac1dba53e9d31c | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 2.08e-03 | 132 | 23 | 2 | e0733a41d2281d25786b9fd1da629f2e58f15b67 | |
| Drug | Ethynylestradiol 3-methyl ether [72-33-3]; Down 200; 12.8uM; HL60; HT_HG-U133A | 1.47e-06 | 200 | 23 | 5 | 3008_DN | |
| Drug | 17-AAG; Up 200; 1uM; HL60; HT_HG-U133A | 2.85e-05 | 178 | 23 | 4 | 2685_UP | |
| Drug | AC1LAKND | 3.28e-05 | 62 | 23 | 3 | CID000470146 | |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 3.91e-05 | 193 | 23 | 4 | 3347_UP | |
| Drug | Sulfamonomethoxine [1220-83-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | 3.99e-05 | 194 | 23 | 4 | 2742_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 4.07e-05 | 195 | 23 | 4 | 3282_UP | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 4.15e-05 | 196 | 23 | 4 | 4281_UP | |
| Drug | Pilocarpine nitrate [148-72-1]; Down 200; 14.8uM; HL60; HT_HG-U133A | 4.15e-05 | 196 | 23 | 4 | 2438_DN | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; HL60; HT_HG-U133A | 4.23e-05 | 197 | 23 | 4 | 6131_UP | |
| Drug | (+)-Isoproterenol (+)-bitartrate salt [14638-70-1]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.32e-05 | 198 | 23 | 4 | 3384_UP | |
| Drug | Bergenin monohydrate [477-90-7]; Down 200; 11.6uM; HL60; HT_HG-U133A | 4.32e-05 | 198 | 23 | 4 | 2726_DN | |
| Drug | Tiapride hydrochloride [51012-33-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 4.40e-05 | 199 | 23 | 4 | 2292_UP | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 4.49e-05 | 200 | 23 | 4 | 2648_UP | |
| Drug | BAPN | 4.92e-05 | 71 | 23 | 3 | CID000001647 | |
| Drug | halofuginone lactate | 8.43e-05 | 85 | 23 | 3 | CID000062891 | |
| Drug | allosamidin | 1.02e-04 | 15 | 23 | 2 | CID000119339 | |
| Drug | 4-hydroxyproline | 1.03e-04 | 91 | 23 | 3 | CID000000825 | |
| Drug | 3-deazaguanine | 1.32e-04 | 17 | 23 | 2 | CID000055709 | |
| Drug | valyl-glycine | 1.48e-04 | 18 | 23 | 2 | CID000136487 | |
| Drug | ticlopidine | 1.49e-04 | 103 | 23 | 3 | CID000005472 | |
| Drug | hydroxylysine | 1.76e-04 | 109 | 23 | 3 | CID000001029 | |
| Drug | Tranilast sodium | 2.07e-04 | 115 | 23 | 3 | CID000005527 | |
| Drug | mobs | 2.23e-04 | 22 | 23 | 2 | CID003674064 | |
| Drug | (2s,5s)-5-Carboxymethylproline | 2.55e-04 | 314 | 23 | 4 | CID000447989 | |
| Drug | pirfenidone | 3.53e-04 | 138 | 23 | 3 | CID000040632 | |
| Drug | DL-penicillamine | 3.61e-04 | 139 | 23 | 3 | CID000004727 | |
| Drug | PCR 4099 | 3.61e-04 | 139 | 23 | 3 | CID000002806 | |
| Drug | acetic acids | 3.63e-04 | 28 | 23 | 2 | CID000031229 | |
| Drug | GK-101 | 6.02e-04 | 36 | 23 | 2 | CID000161853 | |
| Drug | khellin | 6.60e-04 | 171 | 23 | 3 | CID000003828 | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A | 6.71e-04 | 172 | 23 | 3 | 3979_UP | |
| Drug | chondroitin sulfate | 7.19e-04 | 413 | 23 | 4 | CID000024766 | |
| Drug | AC1L1DD6 | 7.54e-04 | 179 | 23 | 3 | CID000002299 | |
| Drug | Rifabutin [72559-06-9]; Up 200; 4.8uM; MCF7; HT_HG-U133A | 7.78e-04 | 181 | 23 | 3 | 4349_UP | |
| Drug | F0447-0125; Down 200; 10uM; PC3; HT_HG-U133A | 8.16e-04 | 184 | 23 | 3 | 6429_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 8.42e-04 | 186 | 23 | 3 | 4463_UP | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; HL60; HG-U133A | 8.55e-04 | 187 | 23 | 3 | 2017_UP | |
| Drug | Mometasone furoate [83919-23-7]; Up 200; 7.6uM; PC3; HT_HG-U133A | 8.55e-04 | 187 | 23 | 3 | 5116_UP | |
| Drug | Colchicine [64-86-8]; Up 200; 10uM; PC3; HT_HG-U133A | 9.09e-04 | 191 | 23 | 3 | 4614_UP | |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 9.09e-04 | 191 | 23 | 3 | 2250_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | 9.23e-04 | 192 | 23 | 3 | 3114_UP | |
| Drug | Theobromine [83-67-0]; Down 200; 22.2uM; PC3; HT_HG-U133A | 9.37e-04 | 193 | 23 | 3 | 6613_DN | |
| Drug | pioglitazone HCl; Up 200; 10uM; PC3; HT_HG-U133A | 9.37e-04 | 193 | 23 | 3 | 6893_UP | |
| Drug | Sulfadiazine [68-35-9]; Down 200; 16uM; HL60; HT_HG-U133A | 9.37e-04 | 193 | 23 | 3 | 1852_DN | |
| Drug | Nilutamide [63612-50-0]; Down 200; 12.6uM; HL60; HT_HG-U133A | 9.37e-04 | 193 | 23 | 3 | 3104_DN | |
| Drug | 1zd2 | 9.41e-04 | 45 | 23 | 2 | CID004149241 | |
| Drug | Finasteride [98319-26-7]; Down 200; 10.8uM; HL60; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 2206_DN | |
| Drug | Luteolin [491-70-3]; Up 200; 14uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 3379_UP | |
| Drug | Sertaconazole nitrate [99592-39-9]; Down 200; 8uM; HL60; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 6128_DN | |
| Drug | Kawain [500-64-1]; Up 200; 17.4uM; MCF7; HT_HG-U133A | 9.51e-04 | 194 | 23 | 3 | 2299_UP | |
| Drug | monastrol; Up 200; 100uM; MCF7; HG-U133A | 9.66e-04 | 195 | 23 | 3 | 311_UP | |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; PC3; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 4312_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 3977_UP | |
| Drug | Melatonin [73-31-4]; Up 200; 17.2uM; PC3; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 6293_UP | |
| Drug | Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; HL60; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 2707_DN | |
| Drug | Trihexyphenidyl-D,L Hydrochloride [58947-95-8]; Down 200; 11.8uM; PC3; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 4015_DN | |
| Drug | (-)-Eseroline fumarate salt [104015-29-4]; Down 200; 12uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 3530_DN | |
| Drug | haloperidol; Down 200; 10uM; HL60; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 1144_DN | |
| Drug | Amoxicillin [26787-78-0]; Up 200; 11uM; MCF7; HT_HG-U133A | 9.66e-04 | 195 | 23 | 3 | 5385_UP | |
| Drug | Sulfadimethoxine [122-11-2]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4724_UP | |
| Drug | Sulfamethoxazole [723-46-6]; Up 200; 15.8uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2335_UP | |
| Drug | Enoxacin [74011-58-8]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 5251_UP | |
| Drug | Hymecromone [90-33-5]; Up 200; 22.8uM; PC3; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4623_UP | |
| Drug | Naphazoline hydrochloride [550-99-2]; Down 200; 16.2uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4949_DN | |
| Drug | Melatonin [73-31-4]; Down 200; 17.2uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2431_DN | |
| Drug | Lithocholic acid [434-13-9]; Down 200; 10.6uM; PC3; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 3816_DN | |
| Drug | Cisapride [81098-60-4]; Down 200; 8.6uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2443_DN | |
| Drug | Asiaticoside [16830-15-2]; Up 200; 4.2uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2943_UP | |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2935_DN | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4416_DN | |
| Drug | Lomefloxacin hydrochloride [98079-52-8]; Up 200; 10.4uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2310_UP | |
| Drug | Guanadrel sulfate [22195-34-2]; Up 200; 7.6uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 4720_UP | |
| Drug | cox-2 inhibitor I; Up 200; 10uM; MCF7; HG-U133A | 9.80e-04 | 196 | 23 | 3 | 253_UP | |
| Drug | Amphotericin B [1397-89-3]; Down 200; 4.4uM; HL60; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 2441_DN | |
| Drug | prednisolone; Down 200; 1uM; MCF7; HG-U133A | 9.80e-04 | 196 | 23 | 3 | 265_DN | |
| Drug | Chloramphenicol [56-75-7]; Up 200; 12.4uM; MCF7; HT_HG-U133A | 9.80e-04 | 196 | 23 | 3 | 5466_UP | |
| Drug | Madecassol | 9.83e-04 | 46 | 23 | 2 | CID000108062 | |
| Drug | Parbendazole [14255-87-9]; Up 200; 16.2uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 3881_UP | |
| Drug | R(+)-verapamil hydrochloride; Down 200; 10uM; MCF7; HG-U133A | 9.94e-04 | 197 | 23 | 3 | 164_DN | |
| Drug | Chlorogenic acid [327-97-9]; Up 200; 11.2uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 4024_UP | |
| Drug | estradiol, USP; Down 200; 0.1uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2668_DN | |
| Drug | Scopolamin-N-oxide hydrobromide [6106-81-6]; Down 200; 10uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 5436_DN | |
| Drug | Aminocaproic acid [60-32-2]; Down 200; 30.4uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 3122_DN | |
| Drug | Betulinic acid [472-15-1]; Up 200; 8.8uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 4181_UP | |
| Drug | clozapine; Down 200; 10uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 5589_DN | |
| Drug | Harmalol hydrochloride dihydrate [6028-07-5]; Up 200; 14.6uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 5495_UP | |
| Drug | Azapropazone [13539-59-8]; Up 200; 13.4uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 3143_UP | |
| Drug | Prazosin hydrochloride [19237-84-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 6475_UP | |
| Drug | Acetaminophen [103-90-2]; Down 200; 26.4uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 3364_DN | |
| Drug | Raloxifene hydrochloride [82640-04-8]; Down 200; 7.8uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 2738_DN | |
| Drug | Dantrolene sodium salt [14663-23-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 3978_UP | |
| Drug | Nisoxetine hydrochloride [57754-86-6]; Up 200; 13uM; HL60; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 3117_UP | |
| Drug | WY-14643; Up 200; 100uM; PC3; HG-U133A | 9.94e-04 | 197 | 23 | 3 | 464_UP | |
| Drug | Dinoprost trometamol [38362-01-5]; Down 200; 8.4uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 3308_DN | |
| Drug | Prochlorperazine dimaleate [84-02-6]; Up 200; 6.6uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 6664_UP | |
| Drug | Medrysone [2668-66-8]; Up 200; 11.6uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 4266_UP | |
| Drug | Hyoscyamine (L) [101-31-5]; Up 200; 13.8uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 5099_UP | |
| Drug | Hydrocotarnine hydrobromide [5985-00-2]; Up 200; 13.2uM; PC3; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 4489_UP | |
| Drug | Carbinoxamine maleate salt [3505-38-2]; Up 200; 9.8uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 3466_UP | |
| Drug | Pentylenetetrazole [54-95-5]; Up 200; 29uM; MCF7; HT_HG-U133A | 9.94e-04 | 197 | 23 | 3 | 5508_UP | |
| Disease | 4-hydroxyphenylacetylglutamine measurement | 1.59e-06 | 3 | 22 | 2 | EFO_0800688 | |
| Disease | indoleacetylglutamine measurement | 7.95e-06 | 6 | 22 | 2 | EFO_0800035 | |
| Disease | atrophic macular degeneration, age-related macular degeneration, wet macular degeneration | 9.15e-04 | 60 | 22 | 2 | EFO_0001365, EFO_0004683, EFO_1001492 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PFAMDKKAVPGGGMP | 286 | Q09472 | |
| MMPGKTKADAADPAP | 191 | Q03989 | |
| MKPAVDEMFPEGAGP | 1 | Q8WXC6 | |
| FGPEMKKLISCPGMP | 456 | Q9NQI0 | |
| PGDMGKKGEMGQPGP | 1076 | Q01955 | |
| KMPKFSMPGFKAEGP | 881 | Q09666 | |
| MPKFSMPSLKGEGPE | 1131 | Q09666 | |
| KMPKFSMPGFKGEGP | 1386 | Q09666 | |
| PKFSMPGFKGEGPEV | 1516 | Q09666 | |
| KMPKFSMPGFKAEGP | 1716 | Q09666 | |
| MPKISMPGFKGEGPD | 2771 | Q09666 | |
| KMPKFSMPGFKGEGP | 3026 | Q09666 | |
| PKISMPGFKGEGPEV | 3156 | Q09666 | |
| KMPKFSMPGFKGEGP | 3606 | Q09666 | |
| KMPKISMPGFKGEGP | 3936 | Q09666 | |
| PKFSMPGFKGEGPEV | 4066 | Q09666 | |
| MPKFSMPGFKGEGPD | 4321 | Q09666 | |
| KMPKFSMPGFKGEGP | 4656 | Q09666 | |
| GEGPPKMDLMAFSPS | 761 | Q9UN73 | |
| PGMLGQKGEMGPKGE | 206 | Q9Y215 | |
| APMEGKGSRPKNMTP | 871 | Q14118 | |
| MAASKVKQDMPPPGG | 1 | Q9P0J0 | |
| LSIQGMPGMPGEKGE | 1511 | Q05707 | |
| MPGMPGEKGEKGDTG | 1516 | Q05707 | |
| EKGPPNGMMPAPKEA | 226 | O00257 | |
| PGKPGAMGMPGAKGE | 166 | P27658 | |
| QPEGMAAKPVMEPPG | 441 | Q7Z601 | |
| GKGDPVAPGRMDPMT | 191 | Q7Z2K8 | |
| TVPVPCGIGPKMDGM | 371 | Q9BZE2 | |
| NPPGPSPKALAKMMG | 1101 | O95785 | |
| PKFKMPSFGMLSPGK | 4466 | Q8IVF2 | |
| GMKIKPGFMGKATPP | 381 | Q08AH1 | |
| MKIKPGSMGKPSPAF | 391 | Q53FZ2 | |
| FGGVKPMGSEPVPKS | 611 | Q9UJS0 | |
| MPGKPKHLGVPNGRM | 1 | O43566 | |
| DPPKMGMPVVRGGQT | 36 | Q96KM6 |